Our laboratory is pursuing a research program that focuses on structural studies of human viruses and viral proteins. All of the studies fit into an overall program in the laboratory that concentrates on using three-dimensional structural information to aid the design of antiviral agents and vaccines. Although there are significant obstacles to developing effective treatments for many important infectious diseases, increases in our fundamental knowledge about the molecular mechanisms of diseases and the agents that cause them are likely to be essential for success. In addition to the biomedical implications of this information, the structural data from these studies also have value for fundamental understanding of large molecular assemblies that involve interactions of proteins and nucleic acids. Given the size of the systems that are being studied, synchrotron radiation is required for obtaining reliable structures. During the previous project period we have solved several structures of 1 reverse transcriptase (RT) using diffraction data collected with synchrotron X-radiation at CHESS. We have also obtained initial solutions for two virus structures (coxsackievirus B1 complexed with an antiviral compound and an HRV14:HIV-1 immunogenic chimera). The structure of HIV-1 RT complexed with a dsDNA template-primer and a monoclonal antibody Fab fragment has been solved at 3.0 _ resolution (Jacobo-Molina et al., 1993) refined at 2.8 _ resolution (Ding et al., in preparation). The structures of HIV-1 RT complexed with a number of nonnucleoside RT inhibitors, including a-APA (Ding et al., 1995), 8-Cl TIBO (R86183) (Ding et al., 1995), and 9-Cl TIBO (R82913) (Das et al., submitted) have been solved at 2.8 _, 3.0 _, and 3.0 _ resolution, respectively. The structure of unliganded HIV-1 RT has also been determined and refined at 2.7 _ resolution (Hsiou et al., submitted). These will will serve as reference structures for the HIV-1 RT structural studies proposed here.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR001646-14
Application #
5223528
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle (2018) Crystal structure of the Legionella effector Lem22. Proteins 86:263-267
Ménade, Marie; Kozlov, Guennadi; Trempe, Jean-François et al. (2018) Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations. J Biol Chem 293:12832-12842
Xu, Jie; Kozlov, Guennadi; McPherson, Peter S et al. (2018) A PH-like domain of the Rab12 guanine nucleotide exchange factor DENND3 binds actin and is required for autophagy. J Biol Chem 293:4566-4574
Dean, Dexter N; Rana, Pratip; Campbell, Ryan P et al. (2018) Propagation of an A? Dodecamer Strain Involves a Three-Step Mechanism and a Key Intermediate. Biophys J 114:539-549
Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan et al. (2018) The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity. J Biol Chem 293:19998-20007
Xu, Caishuang; Kozlov, Guennadi; Wong, Kathy et al. (2016) Crystal Structure of the Salmonella Typhimurium Effector GtgE. PLoS One 11:e0166643
Cogliati, Massimo; Zani, Alberto; Rickerts, Volker et al. (2016) Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population. Fungal Genet Biol 87:22-9
Oot, Rebecca A; Kane, Patricia M; Berry, Edward A et al. (2016) Crystal structure of yeast V1-ATPase in the autoinhibited state. EMBO J 35:1694-706
Lucido, Michael J; Orlando, Benjamin J; Vecchio, Alex J et al. (2016) Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry 55:1226-38
Bauman, Joseph D; Harrison, Jerry Joe E K; Arnold, Eddy (2016) Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ 3:51-60

Showing the most recent 10 out of 375 publications